Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
CDER
Biotech
FDA’s rare disease framework aims to ‘stand the test of time’
Although more details of the framework are forthcoming, CBER Director Karim Mikahil said "the vision here is for this to be a true quantum leap."
Marissa Russo
Oct 28, 2026 3:16pm
Fierce Pharma
FDA solidifies leadership posts at CDER, CBER
Sep 9, 2026 9:00am
Fierce Pharma
CDER chief Høeg and CBER's Szarama exiting FDA posts
May 15, 2026 1:44pm
Can’t plausible mechanism principles apply to uniQure?
Apr 15, 2026 4:00am
Yet another CDER leadership shake-up—Chutes & Ladders
Dec 5, 2025 8:30am
FDA names Tracy Beth Høeg as acting head of drug center
Dec 4, 2025 4:03am